SCHEMBL4272473

SCHEMBL4272473

Cc1cccc(C=Cc2ccc3c(c2)NC(=O)CO3)c1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.65
NR3C2 P08235 5/20 0.58
MAOB P27338 1/20 0.55
ALDH1A1 P00352 2/20 0.52
LMNA P02545 1/20 0.52
PKM P14618 2/20 0.51
BRD4 O60885 1/20 0.50
CREBBP Q92793 1/20 0.50
PARP1 P09874 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.49
MAPT P10636 2/20 0.48
TP53 P04637 1/20 0.48
RAF1 P04049 1/20 0.47
BRAF P15056 1/20 0.47
TRPV1 Q8NER1 2/20 0.46
PTGS1 P23219 1/20 0.46
PTGS2 P35354 1/20 0.46
KMT2A Q03164 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13932083 1.00 MMP12 (0.65) MMP12NR3C2MAOBALDH1A1LMNA
SCHEMBL4267374 0.86 ALDH1A1 (0.67) MMP12NR3C2MAOBALDH1A1LMNA
SCHEMBL13932080 0.86 ALDH1A1 (0.67) MMP12NR3C2MAOBALDH1A1LMNA
SCHEMBL4267779 0.85 NR3C2 (0.59) MMP12NR3C2ALDH1A1LMNAPKM
SCHEMBL13932054 0.85 NR3C2 (0.59) MMP12NR3C2ALDH1A1LMNAPKM
SCHEMBL13932085 0.84 NR3C2 (0.61) MMP12NR3C2ALDH1A1LMNAPKM
SCHEMBL13932049 0.84 MMP12 (0.64) MMP12NR3C2ALDH1A1LMNAPKM
SCHEMBL4269356 0.84 MMP12 (0.64) MMP12NR3C2ALDH1A1LMNAPKM
SCHEMBL4263496 0.84 NR3C2 (0.61) MMP12NR3C2ALDH1A1LMNAPKM
SCHEMBL13932042 0.83 NR3C2 (0.63) MMP12NR3C2ALDH1A1LMNAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054417-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS IRM LLC (BM) 2009-02-26 US claimed
US-20090054417-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS IRM LLC (BM) 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054417-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS NR5A1, ESRRA, NR3C1 MMP12 2999/4885NR3C2 7/4885MAOB 4509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.